2-Allylphenol

2-Allylphenol

SCHEMBL5487968

C=CCc1ccccc1O.OCC(O)CO

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.46
GABRB2 P47870 3/20 0.46
AKR1B1 P15121 1/20 0.43
ALDH1A1 P00352 1/20 0.42
HSPA5 P11021 1/20 0.42
ADRB2 P07550 4/20 0.40
ADRB1 P08588 4/20 0.40
LMNA P02545 2/20 0.40
CYP2D6 P10635 2/20 0.40
TSHR P16473 2/20 0.40
ADRB3 P13945 2/20 0.40
HTR1A P08908 1/20 0.40
ADRA2C P18825 1/20 0.40
SLC6A2 P23975 1/20 0.40
BDKRB2 P30411 1/20 0.40
SLC6A4 P31645 1/20 0.40
ADRA1A P35348 1/20 0.40
HTR2B P41595 1/20 0.40
KCNH2 Q12809 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Allylphenol SCHEMBL11259874 0.89 ALDH1A1 (0.42) GABRA1GABRB2AKR1B1ALDH1A1ADRB2
2-Allylphenol SCHEMBL27575089 0.89 ALDH1A1 (0.44) GABRA1GABRB2AKR1B1ALDH1A1ADRB2
2-Allylphenol SCHEMBL10672983 0.88 GABRA1 (0.44) GABRA1GABRB2AKR1B1ALDH1A1HSPA5
2-Allylphenol SCHEMBL2295999 0.87 GABRA1 (0.53) GABRA1GABRB2AKR1B1ALDH1A1HSPA5
2-Allylphenol SCHEMBL160157 0.87 GABRA1 (0.57) GABRA1GABRB2AKR1B1HSPA5CYP2D6
2-Allylphenol SCHEMBL5489147 0.87 GABRA1 (0.57) GABRA1GABRB2AKR1B1HSPA5CYP2D6
2-Allylphenol SCHEMBL29381085 0.87 GABRA1 (0.57) GABRA1GABRB2AKR1B1HSPA5CYP2D6
2-Allylphenol SCHEMBL31591833 0.87 GABRA1 (0.57) GABRA1GABRB2AKR1B1HSPA5CYP2D6
2-Allylphenol SCHEMBL176552 0.85 GABRA1 (0.52) GABRA1GABRB2AKR1B1ALDH1A1HSPA5
2-Allylphenol SCHEMBL1509626 0.85 GABRA1 (0.55) GABRA1GABRB2AKR1B1HSPA5CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189267-B2 Oxyethylenated based hair pre-treatment anti-penetration composition and method using such a composition for limiting the penetration of dyes into the skin L'OREAL (FR) 2007-03-13 US disclosed
US-20040231071-A1 Oxyethylenated based hair pre-treatent anti-penetration composition and method using such a composition for limiting the penetration of dyes into the skin L'OREAL (FR) 2004-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040231071-A1 Oxyethylenated based hair pre-treatent anti-penetration composition and method using such a composition for limiting the penetration of dyes into the skin KRT18, CUTA, COL14A1 GABRA1 4419/4885GABRB2 4110/4885AKR1B1 539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.